春来春往
05-26
维立志博PD-L1/4-1BB双抗LBL-024获中美双突破,是个里程碑的事情,不仅仅是在技术上,效果相对优秀、适应症广、而且前景大,维立志博上市后LBL-024就是一个藏不住的估值锚
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":439188464484560,"tweetId":"439188464484560","gmtCreate":1748228193368,"gmtModify":1748228194992,"author":{"id":4130588704550290,"idStr":"4130588704550290","authorId":4130588704550290,"authorIdStr":"4130588704550290","name":"春来春往","avatar":"https://static.tigerbbs.com/c7437b6d6248976f55420f5dcd4590a2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>维立志博PD-L1/4-1BB双抗LBL-024获中美双突破,是个里程碑的事情,不仅仅是在技术上,效果相对优秀、适应症广、而且前景大,维立志博上市后LBL-024就是一个藏不住的估值锚</body></html>","htmlText":"<html><head></head><body>维立志博PD-L1/4-1BB双抗LBL-024获中美双突破,是个里程碑的事情,不仅仅是在技术上,效果相对优秀、适应症广、而且前景大,维立志博上市后LBL-024就是一个藏不住的估值锚</body></html>","text":"维立志博PD-L1/4-1BB双抗LBL-024获中美双突破,是个里程碑的事情,不仅仅是在技术上,效果相对优秀、适应症广、而且前景大,维立志博上市后LBL-024就是一个藏不住的估值锚","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/439188464484560","repostId":0,"isVote":1,"tweetType":1,"viewCount":532,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":153,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/439188464484560"}
精彩评论